Skip to main content

Table 2 Physical Activity Baseline and Follow-up in Both Study Groups

From: “Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”

 

Intervention Group

(n = 20)

Usual Care Group

(n = 20)

Total

(N = 40)

P-value

Self-Reported Physical Activity (minutes)

Baseline weekly exercise minutes (moderate + vigorous)

  Mean (SD)

37.0 (46.4)

58.8 (55.8)

47.9 (51.8)

0.25

  Median (Range)

8 (0–125)

60 (0–140)

30 (0–140)

Weekly exercise minutes (moderate + vigorous) at study completion

 

  Mean (SD)

160.1 (231.2)

92.6 (124.4)

127.2 (187.7)

0.52

  Median (Range)

43 (0–861)

0 (0–330)

15 (0–861)

Change between Week 1 and Week 12

 

  Mean (SD)

123.01 (212.0)

34.7 (102.7)

80 (171.6)

0.051a

  Median

8 (−60–811)

0 (− 120–225)

0 (−120–811)

Step Counts

  Average step count, baseline, (range, n = 19) (week 1)

4707 (1568-12,222)

N/A

N/A

 

  Average step count, midway (range, n = 18) (week 6)

5605 (1079-9764)

  

0.16

  Mean change (midway vs baseline, n = 18; range)

893 (− 5139–4874)

   

  Average step count, last week (range)

4606 (746–10,238)

  

0.87

  Mean change (baseline vs last week; range)

−107 (− 6495-4163)

   
  1. ap-value is calculated in linear model controlling patient gender and baseline exercise minutes